Literature DB >> 22790593

HCl-induced and ATP-dependent upregulation of TRPV1 receptor expression and cytokine production by human esophageal epithelial cells.

Jie Ma1, Annamaria Altomare, Michele Guarino, Michele Cicala, Florian Rieder, Claudio Fiocchi, Dan Li, Weibiao Cao, Jose Behar, Piero Biancani, Karen M Harnett.   

Abstract

The pathogenesis of gastroesophageal reflux disease (GERD) remains elusive, but recent evidence suggests that early secretion of inflammatory cytokines and chemokines by the mucosa leads to influx of immune cells followed by tissue damage. We previously showed that exposure of esophageal mucosa to HCl causes ATP release, resulting in activation of acetyl-CoA:1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (lyso-PAF AT), the enzyme responsible for the production of platelet-activating factor (PAF). In addition, HCl causes release of IL-8 from the esophageal mucosa. We demonstrate that esophageal epithelial cells secrete proinflammatory mediators in response to HCl and that this response is mediated by ATP. Monolayers of the human esophageal epithelial cell line HET-1A were exposed to acidified cell culture medium (pH 5) for 12 min, a total of seven times over 48 h, to simulate the recurrent acid exposure clinically occurring in GERD. HCl upregulated mRNA and protein expression for the acid-sensing transient receptor potential cation channel, subfamily vanilloid member 1 (TRPV1), lyso-PAF AT, IL-8, eotaxin-1, -2, and -3, macrophage inflammatory protein-1α, and monocyte chemoattractant protein-1. The chemokine profile secreted by HET-1A cells in response to repeated HCl exposure parallels similar findings in erosive esophagitis patients. In HET-1A cells, the TRPV1 agonist capsaicin reproduced these findings for mRNA of the inflammatory mediators lyso-PAF AT, IL-8, and eotaxin-1. These effects were blocked by the TRPV1 antagonists iodoresiniferatoxin and JNJ-17203212. These effects were imitated by direct application of ATP and blocked by the nonselective ATP antagonist suramin. We conclude that HCl/TRPV-induced ATP release upregulated secretion of various chemoattractants by esophageal epithelial cells. These chemoattractants are selective for leukocyte subsets involved in acute inflammatory responses and allergic inflammation. The data support the validity of HET-1A cells as a model of the response of the human esophageal mucosa in GERD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22790593      PMCID: PMC3468560          DOI: 10.1152/ajpgi.00097.2012

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  57 in total

1.  Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia.

Authors:  M Tominaga; M Wada; M Masu
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

Review 2.  Cytokine-regulated accumulation of eosinophils in inflammatory disease.

Authors:  M Lampinen; M Carlson; L D Håkansson; P Venge
Journal:  Allergy       Date:  2004-08       Impact factor: 13.146

Review 3.  Eotaxin and eosinophil recruitment: implications for human disease.

Authors:  S M Rankin; D M Conroy; T J Williams
Journal:  Mol Med Today       Date:  2000-01

4.  Molecular analysis of CCR-3 events in eosinophilic cells.

Authors:  N Zimmermann; B L Daugherty; J M Stark; M E Rothenberg
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

5.  Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants.

Authors:  R C Fitzgerald; B A Onwuegbusi; M Bajaj-Elliott; I T Saeed; W R Burnham; M J G Farthing
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

6.  Histological consequences of gastroesophageal reflux in man.

Authors:  F Ismail-Beigi; P F Horton; C E Pope
Journal:  Gastroenterology       Date:  1970-02       Impact factor: 22.682

7.  Interleukin-8 expression in the esophageal mucosa of patients with gastroesophageal reflux disease.

Authors:  N Yoshida; K Uchiyama; M Kuroda; K Sakuma; S Kokura; H Ichikawa; Y Naito; T Takemura; T Yoshikawa; T Okanoue
Journal:  Scand J Gastroenterol       Date:  2004-09       Impact factor: 2.423

8.  Enhanced expression of interleukin-8 and activation of nuclear factor kappa-B in endoscopy-negative gastroesophageal reflux disease.

Authors:  Hajime Isomoto; Vladimir A Saenko; Yusei Kanazawa; Yoshito Nishi; Akira Ohtsuru; Kenichiro Inoue; Yuko Akazawa; Fuminao Takeshima; Katsuhisa Omagari; Masanobu Miyazaki; Yohei Mizuta; Ikuo Murata; Shunichi Yamashita; Shigeru Kohno
Journal:  Am J Gastroenterol       Date:  2004-04       Impact factor: 10.864

9.  Elevated levels of chemokines in esophageal mucosa of patients with reflux esophagitis.

Authors:  Hajime Isomoto; Aiping Wang; Yohei Mizuta; Yuko Akazawa; Kazuo Ohba; Katsuhisa Omagari; Masanobu Miyazaki; Kunihiko Murase; Tomayoshi Hayashi; Kenichiro Inoue; Ikuo Murata; Shigeru Kohno
Journal:  Am J Gastroenterol       Date:  2003-03       Impact factor: 10.864

Review 10.  Dual signaling and effector pathways mediate human eosinophil activation by platelet-activating factor.

Authors:  Masahiko Kato; Hirohito Kita; Atsushi Tachibana; Yasuhide Hayashi; Yoshiaki Tsuchida; Hirokazu Kimura
Journal:  Int Arch Allergy Immunol       Date:  2004-06       Impact factor: 2.749

View more
  22 in total

1.  P2X7R large pore is partially blocked by pore forming proteins antagonists in astrocytes.

Authors:  Robson X Faria; Ricardo A M Reis; Leonardo G B Ferreira; Paula F T Cezar-de-Mello; Milton O Moraes
Journal:  J Bioenerg Biomembr       Date:  2016-01-30       Impact factor: 2.945

2.  Epithelial-derived nuclear IL-33 aggravates inflammation in the pathogenesis of reflux esophagitis.

Authors:  Jing Shan; Tadayuki Oshima; Taichiro Muto; Koubun Yasuda; Hirokazu Fukui; Jiro Watari; Kenji Nakanishi; Hiroto Miwa
Journal:  J Gastroenterol       Date:  2014-08-17       Impact factor: 7.527

Review 3.  Gastroesophageal reflux disease: Update on inflammation and symptom perception.

Authors:  Annamaria Altomare; Michele Pier Luca Guarino; Silvia Cocca; Sara Emerenziani; Michele Cicala
Journal:  World J Gastroenterol       Date:  2013-10-21       Impact factor: 5.742

Review 4.  Eosinophilic esophagitis: New insights in pathogenesis and therapy.

Authors:  Michele Pier Luca Guarino; Michele Cicala; Jose Behar
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

Review 5.  Proton pump inhibitor responsive esophageal eosinophilia, a distinct disease entity?

Authors:  William Munday; Xuchen Zhang
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

6.  Transient receptor potential vanilloid 1 gene deficiency ameliorates hepatic injury in a mouse model of chronic binge alcohol-induced alcoholic liver disease.

Authors:  Huilin Liu; Juliane I Beier; Gavin E Arteel; Christopher E Ramsden; Ariel E Feldstein; Craig J McClain; Irina A Kirpich
Journal:  Am J Pathol       Date:  2014-10-31       Impact factor: 4.307

7.  Eosinophilic esophagitis: interactions with gastroesophageal reflux disease.

Authors:  Edaire Cheng; Rhonda F Souza; Stuart Jon Spechler
Journal:  Gastroenterol Clin North Am       Date:  2014-03-24       Impact factor: 3.806

8.  Acid burn or cytokine sizzle in the pathogenesis of heartburn?

Authors:  Xiaofang Huo; Rhonda F Souza
Journal:  J Gastroenterol Hepatol       Date:  2013-03       Impact factor: 4.029

9.  [Role of transient receptor potential vanilloid 1 in airway inflammation in asthmatic mice].

Authors:  Shuang Feng; Yuan-Yuan Zhang; Wen-Juan Gao; Xu-Hua Bian; Rui-Ming Shi
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2016-09

10.  Distribution of transient receptor potential cation channel subfamily V member 1-expressing nerve fibers in mouse esophagus.

Authors:  Kenjiro Matsumoto; Takuji Hosoya; Eriko Ishikawa; Kimihito Tashima; Kikuko Amagase; Shinichi Kato; Toshihiko Murayama; Syunji Horie
Journal:  Histochem Cell Biol       Date:  2014-07-08       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.